Medicine by Design funds or co-funds awards to advance research, clinical translation and commercialization of regenerative medicine and stem cell therapies. Principal investigators must have a faculty appointment with the University of Toronto.
Planning for Cycle 2
Medicine by Design is planning a second round of team project (also known as Cycle 2) investments that will launch in September 2019 and last for three years.
Following a review of projects that have already received funding through our Cycle 1 and New Ideas award programs, and conversations with Medicine by Design’s Scientific Advisory Board, Executive Leadership Team and Executive Committee, 10 thematic areas have been prioritized for Cycle 2 funding. Medicine by Design will allocate $1 million per year in each of six areas and $500,000 per year in each of four, for a total investment of roughly $24 million. We believe these investments will best leverage Toronto’s existing and emerging strengths in regenerative medicine, differentiate our program from other regenerative medicine centres, and position Medicine by Design to make the greatest impact by the end of its current seven-year federal grant.
Facilitators have been appointed to lead a consultation process that will determine the specific goals and team composition of each Cycle 2 project. Throughout May, each facilitator will hold an open meeting to discuss and refine the project outline they have developed. The meeting schedule is below (locations will be confirmed soon). We encourage principal investigators who are working in regenerative medicine-related fields and hold appointments at the University of Toronto to attend meetings in all areas to which they would like to contribute. If you cannot attend meetings in person, please send all feedback to Medicine by Design Executive Director Michael Sefton.If you have any questions, please contact Ariana Bradford, director, strategic planning and operations.
160 College St.
|Cardiac||Michael Laflamme||May 1, 2018||10:30 a.m. to 12 p.m.||Red Room|
|Gordon Keller||May 1, 2018||1:30 p.m. to 3 p.m.||Red Room|
|Organoids||Jeff Wrana||May 3, 2018||9 a.m. to 10:30 a.m.||Red Room|
|Hematopoesis||John Dick||May 11, 2018||10 a.m. to 11:30 a.m.||Red Room|
|Shana Kelley||May 14, 2018||10 a.m. to 11:30 a.m.||Red Room|
|Neural||Cindi Morshead||May 17, 2018||10 a.m. to 11:30 a.m.||Black Room|
|Rodrigo Fernandez-Gonzalez||May 17, 2018||11:30 a.m. to 1 p.m.||Black Room|
|Endogenous Repair||Freda Miller||May 17, 2018||1 p.m. to 2:30 p.m.||Black Room|
|J.C. Zúñiga-Pflücker||May 23, 2018||8:30 a.m. to 10 a.m.||Red Room|
|Organ Repair||Mingyao Liu||May 29, 2018||8 a.m. to 9:30 a.m.||Red Room|
Current Opportunities for Principal Investigators
Currently no competitions open.
Current Opportunities for Trainees
2018 Till & McCulloch Meetings Travel Awards
Medicine by Design is pleased to sponsor travel awards to enable trainees in Medicine by Design-funded laboratories to attend the Till & McCulloch Meetings in Ottawa (Nov. 12-14, 2018). Trainees should submit abstracts for poster and oral presentations by July 11, 2018.
Travel grants are available to trainees in the laboratories of Medicine by Design-funded principal investigators to attend conferences, workshops or courses that are directly related to Medicine by Design-funded research.